CEMP

Cempra’s CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Prabha Fernandes Thank you, Robert. Good afternoon everyone. Welcome to our teleconference presentation on our fourth quarter and full year 2013 financial results and update on our activities at the company. … moreView todays social media effects on CEMPView the latest stocks trending across Twitter. Click to view dashboardSee who Cempra is hiring next, click here […]

Cempra, Inc. Reports Fourth Quarter and Full Year 2013 Financial and Operating Results

[GlobeNewswire] – CHAPEL HILL, N.C. — Cempra, Inc. , a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today reported … moreView todays social media effects on CEMPView the latest stocks trending across Twitter. Click to view dashboardSee who Cempra is hiring next, click here to view […]

Cempra, Inc. to Report Fourth Quarter and Full Year 2013 Financial and Operating Results, and Host Conference Call and Webcast on Feb. 27, 2014

[at noodls] – CHAPEL HILL, N.C., Feb. 20, 2014 (GLOBE NEWSWIRE) — Cempra, Inc. (Nasdaq:CEMP) today announced that it will report fourth quarter and full year 2013 financial results and provide a business update after … moreView todays social media effects on CEMPView the latest stocks trending across Twitter. Click to view dashboardSee who Cempra is hiring next, click here […]

Cempra, Inc. to Report Fourth Quarter and Full Year 2013 Financial and Operating Results, and Host Conference Call and Webcast on Feb. 27, 2014

[GlobeNewswire] – CHAPEL HILL, N.C. — Cempra, Inc. today announced that it will report fourth quarter and full year 2013 financial results and provide a business update after the close of U.S. financial markets on Feb. … moreView todays social media effects on CEMPView the latest stocks trending across Twitter. Click to view dashboardSee who Cempra is hiring next, click […]

Cempra Initiates Solithromycin Pediatric Program

[GlobeNewswire] – CHAPEL HILL, N.C. — Cempra, Inc. today announced the dosing of the first patient in its Phase 1 study of solithromycin capsules in children. The clinical trial is funded through Cempra’s contract with … moreView todays social media effects on CEMPView the latest stocks trending across Twitter. Click to view dashboardSee who Cempra is hiring next, click here […]

Cempra’s Solithromycin Demonstrates No QT Effects in Thorough QT Study

[at noodls] – CHAPEL HILL, N.C., Feb. 11, 2014 (GLOBE NEWSWIRE) — Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs … moreView todays social media effects on CEMPView the latest stocks trending across Twitter. Click to view dashboardSee who Cempra is hiring next, click here to view […]

Cempra: Safety Results Solidifying Market Position

moreView todays social media effects on CEMPView the latest stocks trending across Twitter. Click to view dashboardSee who Cempra is hiring next, click here to view […]